Moolec Science Sa · NASDAQ:MLEC
Moolec Science Sa — Investor Presentation (September 2024)
15 slides from Moolec Science Sa's investor presentation, Sep 2, 2024
Slide 1: Institutional Deck September 2024
SCIENCE IN FOOD INGREDIENTS Institutional Deck September 2024 CONFIDENTIAL NASDAQ:MLEC
Slide 2: The Disclaimer
The Disclaimer The information presented herein includes forward-looking statements, projections, and estimates based on Moolec's internal analysis, management estimates, and publicly disclosed information within the industry. These estimates and projections are subject to various risks and uncertai
Slide 3: The Summary
The Summary Moolec Science in a nutshell: our company described in eleven simple words. produces animal proteins in plants to heal the meat production system. NASDAQ:MLEC PAGE .03
Slide 4: The Problem
The Problem ~20% of world's GHG emissions come from 1. CO2 Emissions livestock, land use and crops destined for feed. Livestock production is widely considered to 15,400 liters of water are used to produce 1kg of meat. be unsustainable and 2. Water Consumption ~10% of the global water supply is dest
Slide 5: The Solution
The Solution Traditional Soy Seeds Moolec genetically Crops Feed Livestock engineers soybeans with pig proteins Unsustainable Food to tweak the meat value chain. Moolec´s wn animal protein Plant-gro s Technology Crops Livestock Sustainable Food Anima ineering l proteins - Genetic eng NASDAQ:MLEC PAG
Slide 6: The Technology
The Technology High Yields Achieved ~25% of targeted molecule over total 1 Acre of soluble proteins.1 Piggy Sooy™ Moolec can replicate the same protein Less Water & DNA from animals Carbon Footprint2 ~10 Pigs in plants by using One acre of Piggy SooyTM could From Plants2 potentially save ~60,000 lit
Slide 7: The Product
The Product How Industry Works Ingredients Meat Flavorings (High Cost) Moolec develops Flavor Houses Producing Red Coloring (High Cost) clean label ingredients Functional Ingredients to replace more meat Food Producers of Sausages, and expensive Feed Livestock Meat & Fats as Raw Material Burgers, Nu
Slide 8: The Market
The Market Global Meat Global Processed Meat Target Countries Industry-Retail Products Ingredients and Applications (B2C) (B2B) (B2B Ingredients) Moolec tackles the processed meat ingredient market of commodities Vegetable Proteins and specialities.1 15 B Whole Cut U$ 1 Processed Products U$ 250 Mea
Slide 9: The Business Model
The Business Model Moolec uses current supply chain and B2B Ingredients industry practices to produce and sell its Identity Preservation Program unique ingredients. full control of traceability Processing Modified Growers & Packaging Processed Meat Retail/ Seeds (Contracted) Companies Food Service C
Slide 10: The Capabilities
The Capabilities IP protected countries Moolec operates Current sales & customers in the United States & Argentina, commercializes and protects its IP worldwide. Crop Science, Back Office, +25 Patents Production & Production Cultivation & Cultivation Idaho, Iowa, Missouri, Ohio, Buenos Aires, Córdob
Slide 11: The Product Pipeline
The Product Pipeline PRODUCT DISCOVERY TRANSFORMATION DEVELOPMENT SELECTION SCALE-UP DOWNSTREAM COMMERCIALIZATION ADDRESSABLE REGULATORY MARKET APPROVALS Moolec builds its revenue TSP Valorasoy™ streams with progressive (Textured Soy Proteins) PRESENT U$ 1 B stages based on added GLASO™ FY25 U$ 1,5
Slide 12: The Team
7 3 The Team 4 2 5 6 Moolec is led by 1 a fourth-generation member of one of Latam's largest pork and meat producers. 1 2 3 4 Gastón Paladini, MBA Henk Hoogenkamp, Ph.D Martín Salinas, Ph.D José López Lecube, MBA CEO & Co-Founder CPO & Co-Founder CTO & Co-Founder Chief Financial Officer 20+ years in
Slide 13: The Key Milestones
The Key Milestones Moolec has been delivering TSP GLASO™ Piggy Sooy™ R&D Agreement Valorasoy™ USDA USDA Safflower unpreceded milestones Commercialization Approval Approval Development focusing on results and PEEA1 GLASO™ Piggy Sooy™ commitment to value USDA Approval Commercial Launch Off Take Agreem
Slide 14: The Numbers
FY2022 FY2023 FY20241 The Numbers In millions of U$S (Full Year) (Full Year) (1st Semester) Revenue & Other Income 0.00 0.91 3.41 Cost of Sales 0.00 (1.05) (2.14) Moolec promotes R&D Expenses (0.99) (1.35) (0.90) controlled expenses and Marketing Expenses (0.11) (0.26) (0.34) efficient cash utilizat
Slide 15: Let's redefine the way we produce animal proteins
SCIENCE IN FOOD INGREDIENTS Letˇs redefine the way we produce animal proteins for the good of the planet. Follow us! NASDAQ:MLEC hello@moolecscience.com | ir@moolecscience.com
Moolec Science — Investor Presentation (September 2024) on 6ix